Lindbrook Capital’s Definitive Healthcare DH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$338 Sell
117
-824
-88% -$3.34K ﹤0.01% 2675
2024
Q4
$3.87K Sell
941
-79
-8% -$345 ﹤0.01% 2097
2024
Q3
$4.56K Sell
1,020
-531
-34% -$2.49K ﹤0.01% 2051
2024
Q2
$8.47K Buy
+1,551
New +$9.77K ﹤0.01% 1720
2023
Q4
Sell
-63
Closed -$503 2723
2023
Q3
$503 Sell
63
-969
-94% -$9.73K ﹤0.01% 2540
2023
Q2
$11.4K Buy
1,032
+860
+500% +$8.86K ﹤0.01% 1385
2023
Q1
$1.78K Buy
172
+24
+16% +$283 ﹤0.01% 2294
2022
Q4
$1.63K Buy
+148
New +$1.9K ﹤0.01% 2330

Other funds holding DH

Lindbrook Capital's DH Position: Q1 2025 in Review

Lindbrook Capital reduced its Definitive Healthcare (DH) stake by 88% in Q1 2025, selling an estimated $3.34K and leaving 117 shares worth $338. The position accounts for ﹤0.01% of the portfolio, ranked #2675.

Lindbrook Capital first reported a position in DH in Q4 2022 and has held it in 8 quarters since. The position peaked at $11.4K in Q2 2023. 136 funds tracked by Wall St. Rank hold DH as of Q1 2025.

  • Lindbrook Capital held 117 shares of Definitive Healthcare worth $338 as of Q1 2025.
  • Lindbrook Capital sold 824 Definitive Healthcare shares in Q1 2025, an estimated $3.34K.
  • Definitive Healthcare made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #2675 holding.
  • Lindbrook Capital first reported a position in Definitive Healthcare in Q4 2022 and has held it in 8 quarters since.
  • Lindbrook Capital's Definitive Healthcare position peaked at $11.4K in Q2 2023.
  • 136 funds tracked by Wall St. Rank held Definitive Healthcare as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.